Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by upside80on Jan 19, 2021 5:13pm
207 Views
Post# 32329477

Houston We Have A Problem

Houston We Have A ProblemIt's our sales guy, god love him I sincerely believe Gilles is trying his best but as far as I can tell he doesn't understand how to sell Ceapro to the investment community. After listening to the BioConnect presentation I realized that Gilles spent about 20 minutes talking about the science in very scientific and boring terms (massive yawn fest), and about 2-3 very rushed minutes talking corporate details like target maket size, development pipleine, financial position etc. If Bioconnect has 300+ presentations you need to do way better than that to catch anyones attention. 

In my view this needs to be flipped completely, 20 minutes discussions how the hell CZO is going to grow into a a mid cap status, play up their major customers/relationships with the J&J's of the world, explain in more detail what their plans are for their tech and what issues they solve (in layman's terms!). I also think they need to issue some shares to:

1. Grease the insitutional investor
2. Accelerate thier programs


<< Previous
Bullboard Posts
Next >>